patent ductus arteriosus |
Disease ID | 491 |
---|---|
Disease | patent ductus arteriosus |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:9) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs1056567 | 19336370 | 7185 | TRAF1 | umls:C0013274 | GAD | [Determination of genetic predisposition to patent ductus arteriosus in preterm infants.] | 0.122367032 | 2009 | PHF19 | 9 | 120869767 | A | G |
rs173365 | 19336370 | 1394 | CRHR1 | umls:C0013274 | GAD | [Determination of genetic predisposition to patent ductus arteriosus in preterm infants.] | 0.002367032 | 2009 | CRHR1;MGC57346-CRHR1 | 17 | 45823708 | A | G |
rs1973028 | 19336370 | 3990 | LIPC | umls:C0013274 | GAD | [Determination of genetic predisposition to patent ductus arteriosus in preterm infants.] | 0.002367032 | 2009 | LIPC;LOC101928694 | 15 | 58499155 | T | C |
rs2817399 | 20581741 | 7021 | TFAP2B | umls:C0013274 | BeFree | Three independent risk factors (immature gestation, absence of antenatal glucocorticoid exposure, and presence of the rs2817399(A) allele of the gene TFAP2B) are associated with patent ductus arteriosus (PDAs) that fail to close during prostaglandin inhibition. | 0.126720033 | 2010 | TFAP2B | 6 | 50836808 | A | G |
rs28360521 | 19336370 | 1565 | CYP2D6 | umls:C0013274 | GAD | [Determination of genetic predisposition to patent ductus arteriosus in preterm infants.] | 0.002367032 | 2009 | CYP2D6 | 22 | 42132969 | C | T |
rs397507444 | 24566197 | 4524 | MTHFR | umls:C0013274 | BeFree | Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C gene polymorphisms are associated with the risk of patent ductus arteriosus (PDA) congenital heart defects. | 0.002909916 | 2014 | MTHFR | 1 | 11794407 | T | G |
rs493694 | 19336370 | 5740 | PTGIS | umls:C0013274 | GAD | [Overall, our data support a role for genetic variations in transcription factor AP-2 beta, tumor necrosis factor receptor-associated factor 1, and prostacyclin synthase in the persistent patency of the ductus arteriosus seen in preterm infants.] | 0.122638474 | 2009 | PTGIS;LOC101927486 | 20 | 49566593 | T | C |
rs711752 | 19336370 | 1071 | CETP | umls:C0013274 | GAD | [Determination of genetic predisposition to patent ductus arteriosus in preterm infants.] | 0.002367032 | 2009 | CETP | 16 | 56962299 | G | A |
rs987237 | 19336370 | 7021 | TFAP2B | umls:C0013274 | GAD | [Overall, our data support a role for genetic variations in transcription factor AP-2 beta, tumor necrosis factor receptor-associated factor 1, and prostacyclin synthase in the persistent patency of the ductus arteriosus seen in preterm infants.] | 0.126720033 | 2009 | TFAP2B | 6 | 50835337 | A | G |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:4) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0013274 | digoxin | D004077 | 20830-75-5 | ductus arteriosus, patent | MESH:D004374 | therapeutic | 6880719 | ||
C0013274 | indomethacin | D007213 | 53-86-1 | ductus arteriosus, patent | MESH:D004374 | marker/mechanism | 15232757 | ||
C0013274 | indomethacin | D007213 | 53-86-1 | ductus arteriosus, patent | MESH:D004374 | therapeutic | 10516392 | ||
C0013274 | trimethadione | D014293 | 127-48-0 | ductus arteriosus, patent | MESH:D004374 | marker/mechanism | 550945 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |